Barclays »

CNS Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of CNS Pharmaceuticals (CNSP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in CNS Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including CNS Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CNS Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $91 19 4.79

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding CNS Pharmaceuticals

Ikarian Capital
ADAR1 Capital Management
Stonepine Capital Management
Boothbay Fund Management
Vanguard Fiduciary Trust
Vanguard Capital Management
UBS Group
Tower Research Capital
Barclays
Barrett & Company
Danske Bank A/s
Citigroup

View all funds holding CNS Pharmaceuticals